Tevogen Bio Holdings (TVGN) Treasury Shares (2022 - 2026)

Tevogen Bio Holdings has reported Treasury Shares for 5 years, with the latest figure at $5633.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares fell 98.7% year-over-year to $5633.0; the trailing twelve-month figure through Mar 2026 stood at $5633.0 (down 98.7% YoY), and the FY2025 full-year result was $5633.0, down 78.16% from the prior year.
• Treasury Shares for Q1 2026 stood at $5633.0, roughly flat from $5633.0 in the prior quarter.
• The five-year high for Treasury Shares was $31.1 million in Q2 2025, with the low at -$3613.0 in Q2 2024.
• Historically, Treasury Shares has averaged $9.2 million across 5 years, with a median of $434585.0 in 2025.
• Annual changes were most pronounced in 2025 — Treasury Shares jumped 860429.48% — and 2026, when it tumbled 98.7%.
• Tevogen Bio Holdings' Treasury Shares stood at $9.9 million in 2022, then slumped by 97.8% to $218002.0 in 2023, then slumped by 88.17% to $25792.0 in 2024, then tumbled by 78.16% to $5633.0 in 2025, then changed by 0.0% to $5633.0 in 2026.
• The last three Treasury Shares figures came in at $5633.0 (Q1 2026), $5633.0 (Q4 2025), and $20.0 million (Q3 2025), per Business Quant data.